The cell line development serum market is expected to reach US$ 1,467.92 million by 2027 from US$ 915.58 million in 2019. The market is estimated to grow with a CAGR of 6.1% from 2020 to 2027.
Regenerative medicines have the potential to replace or heal tissues, as well as organs, and normalize congenital defects. Certain age-related abnormalities, diseases, and trauma damage the tissues and organs. Over the last decade of a century, the tissue engineering industry has emerged impressively, and it has now evolved into the broader area of regenerative medicine, which focuses on the development of clinical therapies for the maintenance, repair, replacement, and enhancement of biological function, with the use of cell engineering. Cell line development is a crucial and invariable part of regenerative medicine. Thus, advancements in the regenerative medicine boost the demand for serum used in cell line development.
Cell lines play a major role in testing and development of drugs, development of cell-based therapy, and research related to cancer tissues, among other applications. New drugs developed in pharmaceutical companies are safely and effectively tested on differentiated stem cells for checking their potential. Further, the regenerative medicines using cell-based models have the potential to help the researchers in early-intervention treatment for degenerative diseases and traumatic injuries. Thus, surge in the use of regenerative medicines propels the cell line development serum market
Lucrative Regional Markets for Cell Line Development Serum
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Adoption of Regenerative Medicines
Regenerative medicines have the potential to replace or heal tissues, as well as organs, and normalize congenital defects. Certain age-related abnormalities, diseases, and trauma damage the tissues and organs. Over the last decade of a century, the tissue engineering industry has emerged impressively, and it has now evolved into the broader area of regenerative medicine, which focuses on the development of clinical therapies for the maintenance, repair, replacement, and enhancement of biological function, with the use of cell engineering. Cell line development is a crucial and invariable part of regenerative medicine. Thus, advancements in the regenerative medicine boost the demand for serum used in cell line development.
Cell lines are instrumental in testing and development of drugs, development of cell-based therapy, and research related to cancer tissues, among other applications. New drugs developed in pharmaceutical companies are safely and effectively tested on differentiated stem cells for checking their potential. Further, the regenerative medicines using cell-based models have the potential to help the researchers in early-intervention treatment for degenerative diseases and traumatic injuries. Thus, surge in the use of regenerative medicines propels the cell line development serum market.
Type Insights
Based on type, the cell line development serum market is segmented into fetal bovine serum, adult bovine serum, porcine serum, horse serum, and other animal serum. In 2019, the fetal bovine serum segment accounted for the largest share of the market. Growth of this segment is attributed to increase in blood tests, urine tests, and different imaging procedures.
Global Cell Line Development Serum Market, by Type– 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User Insights
Based on application, the global cell line development serum market is segmented into tissue engineering and regenerative medicines, toxicity testing, research, drug discovery, bioproduction. In 2019, the bioproduction segment held the largest share of the market; whereas, the drug discovery segment is expected to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Serum Market: Strategic Insights
Market Size Value in US$ 915.58 Million in 2019 Market Size Value by US$ 1,467.92 Million by 2027 Growth rate CAGR of 6.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Serum Market: Strategic Insights
| Market Size Value in | US$ 915.58 Million in 2019 |
| Market Size Value by | US$ 1,467.92 Million by 2027 |
| Growth rate | CAGR of 6.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios to meet the growing consumer demand. The cell line development serum market players adopt the collaborations strategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Cell Line Development Serum Market – By Type
- Fetal Bovine Serum
- Adult Bovine Serum
- Porcine Serum
- Horse Serum
- Other Animal Serum
Cell Line Development Serum Market – By Application
- Bioproduction
- Drug Discovery
- Tissue Engineering and Regenerative Medicines
- Toxicity Testing
- Academic Research
Cell Line Development Serum Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Lonza
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Corporation (Merck KGaA)
- (Cytiva) Danaher
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC) Group
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; By Application ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The cell line is established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from other cells. The cell line development market growth is mainly attributed to the serum is broadly important as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. Besides, the serum also regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.
Increasing Adoption of Regenerative Medicines s expected to propel the growth of the Cell Line Development Serum market. Moreover, rising R&D investments and collaborations among by pharmaceutical and biotechnology companies.
The price of Cell Line Development Serum treatment is $ 168.80 for for fetal bovine serum and HyClone Cosmic Calf Serum, New Zealand origin cost at $ 256.00 USD. However, the cost profoundly differs based upon the customization
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cell Line Development Serum Market – By Type
1.3.2 Global Cell Line Development Serum Market – By Application
1.3.3 Global Cell Line Development Serum Market – By Geography
2. Cell Line Development Serum Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell Line Development Serum – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Serum Market in North America: PEST Analysis
4.2.2 Cell Line Development Serum Market in Europe: PEST Analysis
4.2.3 Cell Line Development Serum Market in APAC: PEST Analysis
4.2.4 Cell Line Development Serum Market in MEA: PEST Analysis
4.2.5 Cell Line Development Serum Market – South and Central America PEST Analysis
4.3 Expert Opinion
5. Cell Line Development Serum Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising R&D Investments and Collaborations among by Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk of Contamination, Misidentification, and Random Alternations in Cell Lines
5.3 Key Opportunities
5.3.1 Increasing Vaccine Production
5.4 Future Trends
5.4.1 Drug Development and Adoption of Novel Technologies for Cell Line Development
5.5 Impact Analysis
6. Cell Line Development Serum Market – Global Analysis
6.1 Global Cell Line Development Serum Market Revenue Forecast and Analysis
6.2 Global Cell Line Development Serum Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Cell Line Development Serum Market - Revenue and Forecasts to 2027 – Type
7.1 Overview
7.2 Global Cell Line Development Serum Market, by Type, 2019 & 2027 (% Share)
7.3 Fetal Bovine Serum
7.3.1 Overview
7.3.2 Global Fetal Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Adult Bovine Serum
7.4.1 Overview
7.4.2 Global Adult Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Porcine Serum
7.5.1 Overview
7.5.2 Global Porcine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Horse Serum
7.6.1 Overview
7.6.2 Global Horse Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Other Animal Serum
7.7.1 Overview
7.7.2 Global Other Animal Serum Market Revenue and Forecast to 2027 (US$ Mn)
8. Cell Line Development Serum Market Analysis and Forecasts to 2027 – Application
8.1 Overview
8.2 Global Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
8.3 Drug Discovery
8.3.1 Overview
8.3.2 Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Bioproduction
8.4.1 Overview
8.4.2 Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Tissue Engineering and Regenerative Medicines
8.5.1 Overview
8.5.2 Global Tissue Engineering and Regenerative Medicines Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Toxicity Testing
8.6.1 Overview
8.6.2 Global Toxicity Testing Revenue and Forecast to 2027 (US$ Mn)
8.7 Academic Research
8.7.1 Overview
8.7.2 Global Academic Research Revenue and Forecast to 2027 (US$ Mn)
9. Cell Line Development Serum Market Revenue and Forecast to 2027 – Geographical Analysis
9.1 North America Cell Line Development Serum Market, Revenue and Forecast to2027
9.1.1 Overview
9.1.2 North America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.3 North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.4 North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.5 North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.1.6 US: Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.6.2 US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.6.3 US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.7 Canada Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.7.3 Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.8 Mexico Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.8.3 Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2 Europe Cell Line Development Serum Market Revenue and Forecast to 2027
9.2.1 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.2 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.3 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2.4 Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.2.5 Germany Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.2.5.1 Germany Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.5.2 Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.5.3 Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2.6 UK Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 UK Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.6.2 UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.6.3 UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2.7 France Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 France Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.7.2 France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.7.3 France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2.8 Spain Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 Spain Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.8.2 Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.8.3 Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2.9 Italy
9.2.9.1 Italy Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.9.2 Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.9.3 Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.2.10 Rest of Europe
9.2.10.1 Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.10.2 Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.2.10.3 Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3 Asia Pacific
9.3.1 Overview
9.3.2 APAC Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.3 Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.4 Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3.5 Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.3.6 China
9.3.6.1 China Cell Line Development Serum Market - Revenue and Forecast to 2027 (US$ Mn)
9.3.6.2 China Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.6.3 China Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3.7 Japan
9.3.7.1 Japan Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.7.2 Japan Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.7.3 Japan Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3.8 India
9.3.8.1 India Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.8.2 India Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.8.3 India Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3.9 South Korea
9.3.9.1 South Korea Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.9.2 South Korea Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.9.3 South Korea Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3.10 Australia
9.3.10.1 Australia Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.10.2 Australia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.10.3 Australia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.3.11 Rest of Asia Pacific
9.3.11.1 Rest of Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.11.2 Rest of Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.3.11.3 Rest of Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.4 Middle East and Africa
9.4.1 Overview
9.4.2 Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.3 Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.4.4 Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.4.5 Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.4.6 UAE
9.4.6.1 UAE Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.6.2 UAE Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.4.6.3 UAE Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.4.7 Saudi Arabia
9.4.7.1 Saudi Arabia Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.7.2 Saudi Arabia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.4.7.3 Saudi Arabia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.4.8 South Africa
9.4.8.1 South Africa Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.8.2 South Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.4.8.3 South Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.4.9 Rest of Middle East and Africa
9.4.9.1 Rest of Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.9.2 Rest of Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.4.9.3 Rest of Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.5 South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027
9.5.1 Overview
9.5.2 South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.3 South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.5.4 South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.5.5 South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.5.6 Brazil Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.6.2 Brazil Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.5.6.3 Brazil Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.5.7 Argentina Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.7.2 Argentina Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.5.7.3 Argentina Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.5.8 Rest of South and Central America Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.8.2 Rest of South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.5.8.3 Rest of South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10. Impact Of COVID-19 Pandemic on Global Cell Line Development Serum Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Cell Line Development Serum Market– Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Lonza
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 THERMO FISHER SCIENTIFIC INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sigma-Aldrich Corporation (MERCK KGaA)
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PAN Biotech.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cytiva (Danaher)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Corning Incorporated
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 European Collection of Cell Cultures (ECACC)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bovogen Biologicals Pty Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 WuXi AppTec
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 American Type Culture Collection (ATCC)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 3. US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 4. US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 5. Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 6. Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 9. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 10. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 11. Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 12. Germany Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. UK Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 15. France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 16. France Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 17. Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 18. Spain Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 19. Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 20. Italy Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 21. Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 22. Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 23. Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 24. Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 25. China Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 26. China Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 27. Japan Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 28. Japan Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 29. India Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 30. India Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 31. South Korea Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 32. South Korea Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 33. Australia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 34. Australia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 35. Rest of Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 36. Rest of Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 37. Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 38. Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 39. UAE Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 40. UAE Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 41. Saudi Arabia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 42. Saudi Arabia Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 43. South Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 44. South Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 45. Rest of Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 46. Rest of Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 47. South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 48. South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 49. Brazil Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 50. Brazil Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 51. Argentina Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 52. Argentina Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 53. Rest of South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 54. Rest of South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 55. Organic Developments Done By Companies
Table 56. Inorganic Developments Done By Companies
Table 57. Glossary of Terms, Cell Line Development Serum Market
LIST OF FIGURES
Figure 1. Cell Line Development Serum Market Segmentation
Figure 2. Cell Line Development Serum Market Segmentation, By Region
Figure 3. Global Cell Line Development Serum Market Overview
Figure 4. Fetal Bovine Serum Segment Held Largest Share of Type Segment in Cell Line Development Serum Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Cell Line Development Serum Market, By Geography (US$ Mn)
Figure 7. Global Cell Line Development Serum Market- Leading Country Markets (US$ Mn)
Figure 8. Global Cell Line Development Serum Market, Industry Landscape
Figure 9. Cell Line Development Serum Market in North America: PEST Analysis
Figure 10. Cell Line Development Serum Market in Europe: PEST Analysis
Figure 11. Cell Line Development Serum Market in APAC: PEST Analysis
Figure 12. Cell Line Development Serum Market MEA: PEST Analysis
Figure 13. Cell Line Development Serum Market – South and Central America PEST Analysis
Figure 14. Cell Line Development Serum Market Impact Analysis of Driver and Restraints
Figure 15. Global Cell Line Development Serum Market – Revenue Forecast and Analysis – 2019- 2027
Figure 16. Global Cell Line Development Serum Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning of Key Players in Global Cell Line Development Serum Market
Figure 18. Global Cell Line Development Serum Market, Type, 2019 & 2027 (% Share)
Figure 19. Global Fetal Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. Global Adult Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Global Porcine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 22. Global Horse Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 23. Global Other Animal Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 24. Global Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
Figure 25. Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Global Tissue and Regenerative Medicines Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 28. Global Toxicity Testing Market Revenue and Forecast to 2027 (US$ Mn)
Figure 29. Global Academic Research Market Revenue and Forecast to 2027 (US$ Mn)
Figure 30. North America Cell Line Development Serum Market Overview, By Country — 2019 (US$ Mn)
Figure 31. North America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 32. North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 33. US Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 34. Canada Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 35. Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 36. Europe Cell Line Development Serum Market Revenue, By Country, 2019 (US$ Mn)
Figure 37. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 38. Europe Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 39. Germany Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 40. UK Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 41. France Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 42. Spain Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 43. Italy Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 44. Rest of Europe Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 45. APAC Cell Line Development Serum Market Revenue Overview, By Country (2019) (US$ Mn)
Figure 46. Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 47. Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 48. China Cell Line Development Serum Market - Revenue and Forecast to 2027 (US$ Mn)
Figure 49. Japan Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 50. India Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 51. South Korea Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 52. Australia Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 53. Rest of Asia Pacific Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 54. Middle East and Africa Cell Line Development Serum Market, Revenue Overview, By Country, 2019 (US$ Mn)
Figure 55. Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 56. Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 57. UAE Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 58. Saudi Arabia Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 59. South Africa Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 60. Rest of Middle East and Africa Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 61. South and Central America Cell Line Development Serum Market, Revenue Overview, By Country, 2019 (US$ Mn)
Figure 62. South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 63. South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 64. Brazil Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 65. Argentina Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 66. Rest of South and Central America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 70. Impact Of COVID-19 Pandemic in Rest of the World Market
Figure 71. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Cell Line Development Serum Market
- Lonza
- Thermo Fisher Scientific Inc.,
- Sigma-Aldrich Corporation (MERCK KGaA)
- Cytiva (Danaher)
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Cell Line Development Serum Market
Nov 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2020